SERUM MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEIN LEVEL IS A RISK FOR AORTIC STIFFNESS IN MAINTENANCE HEMODIALYSIS PATIENTS

被引:0
|
作者
Hou, Jia-Sian [1 ]
Lu, Chia-Wen [1 ]
Hsu, Bang-Gee [1 ,2 ]
机构
[1] Hualien Tzu Chi Hosp, Div Nephrol, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan
[2] Tzu Chi Univ, Sch Med, Hualien, Taiwan
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
P1266
引用
收藏
页码:1589 / 1589
页数:1
相关论文
共 50 条
  • [21] Serum malondialdehyde-modified low-density lipoprotein levels on admission predict prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Amioka, Naofumi
    Miyoshi, Toru
    Otsuka, Hiroaki
    Yamada, Daisuke
    Takaishi, Atsushi
    Ueeda, Masayuki
    Hirohata, Satoshi
    Ito, Hiroshi
    JOURNAL OF CARDIOLOGY, 2019, 74 (3-4) : 258 - 266
  • [22] EFFECT OF FEBUXOSTAT ON THE LEVEL OF MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEIN, AS AN OXIDANT MARKER, FROM THE SUB-ANALYSES OF PRIZE STUDY
    Teragawa, Hiroki
    Tanaka, Atsushi
    Fujii, Yuichi
    Ueda, Tomohiro
    Nomura, Shuichi
    Node, Koichi
    JOURNAL OF HYPERTENSION, 2023, 41 : E477 - E477
  • [23] Increased circulating malondialdehyde-modified low-density lipoprotein levels in patients with ergonovine-induced coronary artery spasm
    Ito, Tsuyoshi
    Fujita, Hiroshi
    Tani, Tomomitsu
    Sugiura, Tomonori
    Ohte, Nobuyuki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 475 - 480
  • [24] Increased Circulating Malondialdehyde-Modified Low-Density Lipoprotein Level Is Associated with High-Risk Plaque in Coronary Computed Tomography Angiography in Patients Receiving Statin Therapy
    Ichikawa, Keishi
    Miyoshi, Toru
    Osawa, Kazuhiro
    Miki, Takashi
    Ito, Hiroshi
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [25] Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina
    Yokoi, Masashi
    Ito, Tsuyoshi
    Fujita, Hiroshi
    Sugiura, Tomonori
    Seo, Yoshihiro
    Ohte, Nobuyuki
    CIRCULATION JOURNAL, 2020, 84 (10) : 1837 - 1845
  • [26] Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: Implication of acute coronary events
    Tani, Shigemasa
    Nagao, Ken
    Anazawa, Takeo
    Kawamata, Hirofumi
    Furuya, Shingo
    Fuji, Takeshi
    Takahashi, Hiroshi
    Iida, Kiyoshi
    Matsumoto, Michiaki
    Kumabe, Takamichi
    Sato, Yuichi
    Hirayama, Atsushi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 135 (02) : 202 - 206
  • [27] Microsomal triglyceride transfer protein gene polymorphism strongly influences circulating malondialdehyde-modified low-density lipoprotein
    Okumura, Kenji
    Imamura, Akiko
    Murakami, Ryuichiro
    Takahashi, Ryotaro
    Cheng, Xian Wu
    Numaguchi, Yasushi
    Murohara, Toyoaki
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (09): : 1306 - 1311
  • [28] Role of atheroma liposomes and malondialdehyde-modified low-density lipoproteins in complement activation
    Sorace, JM
    Rollins, S
    Aniagolu, JA
    Mergner, WJ
    Cole, K
    Swartz, GM
    Green, SJ
    PATHOBIOLOGY, 1996, 64 (02) : 73 - 78
  • [29] SPECIFICITY OF RECEPTOR-MEDIATED RECOGNITION OF MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEINS
    HABERLAND, ME
    FOGELMAN, AM
    EDWARDS, PA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (06): : 1712 - 1716
  • [30] SERUM ENDOCAN AS A RISK FACTOR FOR AORTIC STIFFNESS IN PATIENTS ON MAINTENANCE HEMODIALYSIS
    Huang, Hsiang-Jung
    Wu, Tzu-Chiang
    Lai, Yu-Hsien
    Lin, Yu-Li
    Hsu, Bang-Gee
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I538 - I538